Legal 500
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • News & Developments
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • News & Developments
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Data Protection policies
  • Cookies Policy
  • Supplier Code of Conduct
  • Modern Slavery and Human Trafficking Statement
  • Contact Us
  • home
  • Market Intelligence
  • Search

2,094 results found

Use advanced search filters to refine your search

1 filter applied

Advanced search filters

Topics
Countries
Contributor
Content type
Show options
  • Article

    Central Government's Proposal To Define Stem Cell And Stem Cell Based Product Under D&C Rule

    On April 04, 2018, the Ministry of Health and Family Welfare proposed a draft to amend the Drug and Cosmetics Rules, 194510, that defines stem cell and stem cell-based products, to streamline...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Health Ministry Proposes Clinical Establishment (3rd Amendment Rules), 2019

    On July 17, 2019, the Health Ministry placed the draft notification on Clinical Establishment (Central Government) Third Amendment Rules, prescribing ‘minimum standards for different categories...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
S&A Law Offices
  • Article

    Hilleman Laboratories Announces Successful Outcome In Phase I/II Clinical Trials Of Two Under Development Vaccines

    The clinical trials were conducted in partnership with the International Centre for Diarrhoeal Disease Research (ICDDR), Bangladesh.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    India Healthcare Highlights June 2019

    This segment of the newsletter is focused on regulatory reforms from Healthcare and Pharmaceutical sectors in the Indian jurisdiction with collated information on monthly basis via c
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    India Releases Pharmacovigilance Guidance Document For Marketing Authorization Holders Of Pharmaceutical Products

    The Secretary, Ministry of Health and Family Welfare, Government of India has released Pharmacovigilance Guidance Document for Marketing Authorization Holders of Pharmaceutical Products.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Indian Council Of Medical Research (ICMR) Issues National Guidelines For Stem Cell Research - To Curb ‘Rampant' Unethical Therapeutic Practices

    In October 2017, the Indian Council of Medical Research (ICMR) released the National Guidelines for Stem Cell Research.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    NPPA Revises Coronary Stent Price After A Year Of Price Cap

    The National Pharmaceutical Pricing Authority is under constitutional obligation to provide fair, reasonable and affordable price for Coronary Stents and to check unethical profiteering and exploitive pricing.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    NPPA Show Cause Notice To All Manufacturers / Importers / Marketers Of Notified Medical Devices

    In absence of the price list, it becomes difficult to the NPPA to regulate/fix/monitor the prices of scheduled formulation and non scheduled formulations.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Strides Shasun's Rectal Artesunate Capsule Gets WHO Prequalification

    On June 19, 2018, Strides Shasun announced the receipt of prequalification from the World Health Organization for their 100mg Rectal Artesunate Suppositories for the pre-referral management of severe malaria.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    The Critical Analysis Of The New Drugs Pricing Policy : Pros And Cons

    The nod of the Union Cabinet for the new pricing policy is a boon to the Indian pharmaceutical Industry.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    United States FDA Issues Final Rule That Requires Medical Device Trials Outside US To Conform To Good Clinical Practices (GCP)

    On February 20, 2018, the US FDA finalized a rule that requires medical device clinical investigations conducted outside the US to flexibly conform with good clinical practice standards.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    WHO Recommends Quadrivalent Influenza Vaccines For Use In The Northern Hemisphere Influenza Season, 2018-19

    It is recommended that trivalent vaccines contain the B/Colorado/06/2017-like virus, of the B/Victoria/2/87- lineage.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Legality Of Demonetization Of Rs.500 And Rs.1000 Bank Notes

    The Government of India has taken a policy decision that the Bank notes in the denomination of Rs. 500 and Rs. 1000 shall cease to be a legal tender 8th November, 2016 onwards.
    IndiaGovernment, Public Sector
    S&A Law Offices
    S&A Law Offices
  • Article

    International Worker – A Concept Note

    With rapid globalization there has been a surge of manpower being transferred / migrating from one country to another.
    IndiaImmigration
    S&A Law Offices
    S&A Law Offices
  • Article

    Can A Decree Holder Approach The National Company Law Tribunal For Execution Of A Decree? A Discussion In Light Of The Recent Judgement By Nclat

    In the last few years, it has been noticed that the homebuyers struggle to get their decree executed as the orders of the Real Estate Regulatory Authority ("RERA") have not been executed.
    IndiaInsolvency/Bankruptcy/Re-Structuring
    S&A Law Offices
    S&A Law Offices
  • Article

    Empowering MSMEs: Specialized Insolvency Frameworks For Resilience And Growth

    Micro, Small, and Medium Enterprises are the bedrock of India’s economic ecosystem, contributing 30% to the national GDP, over 45% to India’s exports and employing over 24 crore individuals, according to the Annual Report 2024–25 of the Ministry of MSME.
    IndiaInsolvency/Bankruptcy/Re-Structuring
    S&A Law Offices
    S&A Law Offices
  • Article

    Submission Of Working Statements (Form 27)

    This alert is with respect to submission of Working Statements (Form 27) for Patents granted by the Indian Patent Office.
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    Case Study: Louis Vuitton Malletier v. Abdulkhaliq Abdulkader Chamadia & Ors

    On October 5, 2023, the Court granted an ex-parte ad interim injunction restraining the defendants from manufacturing, selling, or dealing in any products bearing the LV marks. Despite being served, the defendants failed to appear or respond, leading to an ex-parte proceeding.
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    Challenges In Plant Variety Protection In India

    In India, the Plant Variety Protection and Farmers Rights (PPVFR) Act, 2001 (‘Act') is a sui generis system that intends to establish an effective system for protection of plant varieties and the rights of plant breeders and farmers.
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    Concept Of Honest Concurrent User Of Trademarks

    An Honest Concurrent use of a Trademark is when two different entities have coexisted for a considerable amount of time while truthfully...
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Showing 621–640 of 2094 results

    PreviousNext
    Legal Intelligence Newsletters